Literature DB >> 11027436

Overexpression of melanoma inhibitory activity (MIA) enhances extravasation and metastasis of A-mel 3 melanoma cells in vivo.

M Guba1, A K Bosserhoff, M Steinbauer, C Abels, M Anthuber, R Buettner, K W Jauch.   

Abstract

The secreted MIA protein is strongly expressed by advanced primary and metastatic melanomas but not in normal melanocytes. Previous studies have shown that MIA serum levels correlate with clinical tumour progression in melanoma patients. To provide direct evidence that MIA plays a role in metastasis of malignant melanomas, A-mel 3 hamster melanoma cells were transfected with sense- and antisense rhMIA cDNA and analysed subsequently for changes in their tumorigenic and metastatic potential. Enforced expression of MIA in A-mel 3 cells significantly increased their metastatic potential without affecting primary tumour growth, cell proliferation or apoptosis rate in hamsters, compared with control or antisense transfected cells. Additionally, MIA overexpressing transfectants showed a higher rate of both tumour cell invasion and extravasation. Cells transfected with MIA antisense generally exerted an opposite response. The above changes in function attributed to the expression of MIA may underlie the contribution of MIA to the malignant phenotype. Copyright 2000 Cancer Research Campaign.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027436      PMCID: PMC2363599          DOI: 10.1054/bjoc.2000.1424

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

Review 1.  Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin.

Authors:  E H Sage; P Bornstein
Journal:  J Biol Chem       Date:  1991-08-15       Impact factor: 5.157

2.  Alteration of homeobox gene expression by N-ras transformation of PA-1 human teratocarcinoma cells.

Authors:  R Buettner; S O Yim; Y S Hong; E Boncinelli; M A Tainsky
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

Review 3.  Tumor cell interactions with the extracellular matrix during invasion and metastasis.

Authors:  W G Stetler-Stevenson; S Aznavoorian; L A Liotta
Journal:  Annu Rev Cell Biol       Date:  1993

4.  Melanoma-inhibiting activity inhibits cell proliferation by prolongation of the S-phase and arrest of cells in the G2 compartment.

Authors:  F X Weilbach; U Bogdahn; M Poot; R Apfel; C Behl; D Drenkard; R Martin; H Hoehn
Journal:  Cancer Res       Date:  1990-11-01       Impact factor: 12.701

5.  Diminished expression of integrin adhesion molecules on human colonic epithelial cells during the benign to malign tumour transformation.

Authors:  A Stallmach; B von Lampe; H Matthes; G Bornhöft; E O Riecken
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

6.  Autocrine tumor cell growth-inhibiting activities from human malignant melanoma.

Authors:  U Bogdahn; R Apfel; M Hahn; M Gerlach; C Behl; J Hoppe; R Martin
Journal:  Cancer Res       Date:  1989-10-01       Impact factor: 12.701

7.  Early interactions of cancer cells with the microvasculature in mouse liver and muscle during hematogenous metastasis: videomicroscopic analysis.

Authors:  V L Morris; I C MacDonald; S Koop; E E Schmidt; A F Chambers; A C Groom
Journal:  Clin Exp Metastasis       Date:  1993-09       Impact factor: 5.150

8.  Increased tumorigenicity of fibronectin receptor deficient Chinese hamster ovary cell variants.

Authors:  C Schreiner; M Fisher; S Hussein; R L Juliano
Journal:  Cancer Res       Date:  1991-03-15       Impact factor: 12.701

9.  Purification and analysis of growth regulating proteins secreted by a human melanoma cell line.

Authors:  R Apfel; F Lottspeich; J Hoppe; C Behl; G Dürr; U Bogdahn
Journal:  Melanoma Res       Date:  1992-12       Impact factor: 3.599

View more
  15 in total

1.  Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formation.

Authors:  Hongren Yao; Donna M Veine; Zhao-Zhu Zeng; Kevin S Fay; Evan D Staszewski; Donna L Livant
Journal:  Clin Exp Metastasis       Date:  2010-03-26       Impact factor: 5.150

Review 2.  Circulating serologic and molecular biomarkers in malignant melanoma.

Authors:  Shanique R Palmer; Lori A Erickson; Ilia Ichetovkin; Daniel J Knauer; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2011-10       Impact factor: 7.616

3.  GFP-transfected tumor cells are useful in examining early metastasis in vivo, but immune reaction precludes long-term tumor development studies in immunocompetent mice.

Authors:  Markus Steinbauer; Markus Guba; Grigore Cernaianu; Gudrun Köhl; Michaela Cetto; Leoni A Kunz-Schughart; Edward K Geissler; Werner Falk; Karl-Walter Jauch
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

4.  Solution structure and dynamics of melanoma inhibitory activity protein.

Authors:  Julie C Lougheed; Peter J Domaille; Tracy M Handel
Journal:  J Biomol NMR       Date:  2002-03       Impact factor: 2.835

5.  Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins.

Authors:  J C Lougheed; J M Holton; T Alber; J F Bazan; T M Handel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

6.  Survival benefit in patients after palliative resection vs non-resection colon cancer surgery.

Authors:  A Beham; M Rentsch; K Püllmann; L Mantouvalou; H Spatz; H J Schlitt; A Obed
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

7.  Misexpression of MIA disrupts lung morphogenesis and causes neonatal death.

Authors:  Sui Lin; Machiko Ikegami; Yan Xu; Anja-Katrin Bosserhoff; Alvin M Malkinson; John M Shannon
Journal:  Dev Biol       Date:  2008-02-15       Impact factor: 3.582

Review 8.  Diagnostic and prognostic biomarkers in melanoma.

Authors:  David Weinstein; Jennifer Leininger; Carl Hamby; Bijan Safai
Journal:  J Clin Aesthet Dermatol       Date:  2014-06

Review 9.  Stepping out of the flow: capillary extravasation in cancer metastasis.

Authors:  Fayth L Miles; Freddie L Pruitt; Kenneth L van Golen; Carlton R Cooper
Journal:  Clin Exp Metastasis       Date:  2007-09-29       Impact factor: 5.150

Review 10.  Emerging Biomarkers in Cutaneous Melanoma.

Authors:  Anna Eisenstein; Estela Chen Gonzalez; Rekha Raghunathan; Xixi Xu; Muzhou Wu; Emily O McLean; Jean McGee; Byungwoo Ryu; Rhoda M Alani
Journal:  Mol Diagn Ther       Date:  2018-04       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.